1. Home
  2. CECO vs VIR Comparison

CECO vs VIR Comparison

Compare CECO & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CECO Environmental Corp.

CECO

CECO Environmental Corp.

HOLD

Current Price

$59.57

Market Cap

2.2B

Sector

Industrials

ML Signal

HOLD

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$8.96

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CECO
VIR
Founded
1966
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Pollution Control Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
1.5B
IPO Year
2002
2019

Fundamental Metrics

Financial Performance
Metric
CECO
VIR
Price
$59.57
$8.96
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
8
Target Price
$77.75
$19.63
AVG Volume (30 Days)
647.3K
2.8M
Earning Date
04-28-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
280.56
17.49
EPS
1.37
N/A
Revenue
N/A
$68,556,000.00
Revenue This Year
$24.84
N/A
Revenue Next Year
$11.51
$1,049.62
P/E Ratio
$41.63
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.57
$4.16
52 Week High
$81.72
$10.91

Technical Indicators

Market Signals
Indicator
CECO
VIR
Relative Strength Index (RSI) 47.87 50.96
Support Level $57.11 $8.67
Resistance Level $63.98 $10.29
Average True Range (ATR) 3.01 0.46
MACD 0.72 -0.15
Stochastic Oscillator 49.24 40.57

Price Performance

Historical Comparison
CECO
VIR

About CECO CECO Environmental Corp.

CECO Environmental Corp is an industrial company, serving industrial air, industrial water, and energy transition markets. It offers various engineered and configured products and solutions, including dampers and diverters, selective catalytic reduction systems, severe-service and industrial cyclones, dust collectors, thermal oxidizers, filtration systems, wet and dry scrubbers, water treatment packages, industrial silencers, etc. These products are offered through brands like Western Airducts, WK, Wakefield Acoustics, Transcend, Verantis, and others. The company's reportable segments are: Engineered Systems, which derive maximum revenue, and Industrial Process Solutions. Geographically, it derives key revenue from the U.S., followed by the Netherlands, the UK, China, and other markets.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

Share on Social Networks: